Status:

NOT_YET_RECRUITING

Evaluation of the Scar Healing Effects of ChitoCare Medical Scar Healing Gel in Women Undergoing Breast Reduction or Mastopexy Surgery (CHITOSCAR)

Lead Sponsor:

Primex ehf

Conditions:

Surgical Scars

Eligibility:

FEMALE

18+ years

Phase:

NA

Brief Summary

Patients undergoing breast reduction or mastopexy surgery will be screened and recruited for participation in the study. Eligible patients will act as their own control with one breast receiving the a...

Eligibility Criteria

Inclusion

  • Written informed consent must be given
  • Female ≥ 18 years old
  • Having planned or very recently (within 21 days) undergone breast reduction or mastopexy surgery on both breasts
  • Not yet begun any treatment aimed at reducing scarring
  • Wound is not infected at the time of enrolment
  • Able to understand and comply with the requirements of the study

Exclusion

  • Patients with serious concomitant disease (cancer, heart failure (NYHA class IV), severe anaemia (Hb\<100 g/L), neoplasia)
  • Any significant condition that may preclude the participant from the study (e.g. severe depression or psychiatric illness)
  • Patients who will require additional surgical procedures during the study
  • Patients diagnosed with autoimmune connective tissue diseases
  • Previous treatment under this clinical protocol
  • Participation in another clinical trial
  • Receiving or scheduled to receive a medication or treatment which, in the opinion of the investigator, is known to interfere with, or affect the rate and quality of wound healing
  • Allergy to shellfish\* (if unknown, the patient may try a small sample of the IP on their intact skin to assess for any potential allergic reaction.)
  • Medical condition likely to require systemic corticosteroids during the study period
  • Pregnant or lactating women
  • Smoker

Key Trial Info

Start Date :

September 1 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

October 1 2026

Estimated Enrollment :

39 Patients enrolled

Trial Details

Trial ID

NCT06992960

Start Date

September 1 2025

End Date

October 1 2026

Last Update

August 14 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Klíníkin Ármúla

Reykjavik, Capital Region, Iceland, 108